Patient Satisfaction with AbobotulinumtoxinA for Aesthetic Use in the Upper Face: A Systematic Literature Review and Post-hoc Analysis of the APPEAL Study

BACKGROUND: AbobotulinumtoxinA (AboBoNT-A; Dysport(®); Ipsen, Boulogne-Billancourt, France/Azzalure(®); Galderma, Lausanne, Switzerland) is a botulinum neurotoxin type A approved for aesthetic use in the treatment of glabellar lines in adult patients under 65 years in Europe, the United States, and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Aesthet Dermatol
Autores principales: Smit, Riekie, Gubanova, Elena, Kaufman, Joely, Landau, Marina, Molina, Beatriz, Andriopoulos, Bill, Maisonobe, Pascal, Prygova, Inna, Redaelli, Alessio
Formato: Artigo
Lenguaje:Inglês
Publicado: Matrix Medical Communications 2021
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8211347/
https://ncbi.nlm.nih.gov/pubmed/34221231
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares